The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Hims & Hers Health Inc shares valued at $3,136,616 were purchased by Melissa Baird on Feb 12 ’25. At $46.34 per share, Melissa Baird acquired 67,687 shares.
Also, Chi Michael sold 7,259 shares, netting a total of over 314,170 in proceeds. Following the sale of shares at $43.28 each, the insider now holds 193,601 shares.
Before that, Okupe Oluyemi had sold 11,581 shares from its account. In a trade valued at $498,100, the Chief Financial Officer traded Hims & Hers Health Inc shares for $43.01 each. Upon closing the transaction, the insider’s holdings decreased to 11,581 shares, worth approximately $6.38 million.
As published in a research note from Citigroup on January 10, 2025, Hims & Hers Health Inc [HIMS] has been rated down from a Neutral to a Sell and the price target has been revised to $25 from $24. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 17, 2024, Morgan Stanley has initiated its “an Overweight” rating for HIMS. Earlier on November 14, 2024, BofA Securities downgraded its rating. Their new recommendation was “an Underperform” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 46.23%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 144.75%. Shares of the company reached a 52-week high of $59.55 on 02/13/25 and a 52-week low of $24.07 on 01/10/25. A 50-day SMA is recorded $32.00, while a 200-day SMA reached $22.44. Nevertheless, trading volume fell to 42.62 million shares from 9.17 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 51.03, which, if violated, would cause prices to drop to 42.88. In the upper region, resistance lies at 63.44. The next price resistance is at 67.70. RSI (Relative Strength Index) is 87.14 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 9.34, which suggests the price will increase in the coming days. Percent R is at 1.22%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
